Babita Agrawal
Edmonton, AB T6G2S3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Host-directed broad-spectrum immunotherapeutic strategy for respiratory infections: Heat-killed Caulobacter crescentus (HKCC) as an innate-immune based biotherapeutic/postbiotic.
Journal: PLoS pathogens
Published: October 27, 2025
Mixed lipopeptide-based mucosal vaccine elicits a long-term bone marrow memory response that is potentially cross-reactive against a broad-spectrum of coronaviruses in mice.
Journal: Frontiers in immunology
Published: April 28, 2025
Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.
Journal: ImmunoHorizons
Published: November 07, 2024
Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens.
Journal: International journal of molecular sciences
Published: August 28, 2024
Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice.
Journal: Frontiers in immunology
Published: March 02, 2023
Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic.
Journal: Cells
Published: November 24, 2022
Stimulation of toll-like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring.
Journal: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
Published: November 18, 2020
Editorial: Heterologous Immunity: Implications and Applications in Vaccines and Immunotherapies.
Journal: Frontiers in immunology
Published: May 16, 2020
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections.
Journal: Frontiers in immunology
Published: July 25, 2019
New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota.
Journal: Clinical and translational medicine
Published: April 22, 2019
Last Updated: 09/26/2026